Health Catalyst Inc (NASDAQ:HCAT) has a beta value of 1.31 and has seen 1.0 million shares traded in the last trading session. The company, currently valued at $364.24M, closed the last trade at $6.22 per share which meant it lost -$0.12 on the day or -1.89% during that session. The HCAT stock price is -131.03% off its 52-week high price of $14.37 and 12.38% above the 52-week low of $5.45. The 3-month trading volume is 622.65K shares.

Health Catalyst Inc (NASDAQ:HCAT) trade information

Sporting -1.89% in the red in last session, the stock has traded in the green over the last five days, when the HCAT stock price touched $6.22 or saw a rise of 4.01%. Year-to-date, Health Catalyst Inc shares have moved -32.83%, while the 5-day performance has seen it change 11.07%. Over the past 30 days, the shares of Health Catalyst Inc (NASDAQ:HCAT) have changed -14.56%.

Health Catalyst Inc (HCAT) estimates and forecasts

Figures show that Health Catalyst Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -9.33% over the past 6 months, with this year growth rate of 120.00%, compared to 20.00% for the industry. Other than that, the company has, however, increased its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -40.00% and 60.00% for the next quarter. Revenue growth from the last financial year stood is estimated to be 4.30%.

16 analysts offering their estimates for the company have set an average revenue estimate of $74.8 million for the current quarter. 16 have an estimated revenue figure of $75.55 million for the next quarter concluding in Jun 2024.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 7.69% over the past 5 years.

HCAT Dividends

Health Catalyst Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.